Jaebok Choi

Washington University in St. Louis — United States

Medicine · Health Sciences

19h-index2.1kcitations78works3.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hematopoietic Stem Cell Transplantation(41), Immune Cell Function and Interaction(32), CAR-T cell therapy research(17), T-cell and B-cell Immunology(16), Acute Myeloid Leukemia Research(15)

Publications78 total

BI-5756 Reduces Graft-Versus-Host Disease Through CB1-Mediated Treg Upregulation
Molecules·2025Open Access
Enhanced stem cell-mediated therapeutic immune modulation with zinc oxide nanoparticles in liver regenerative therapy
Biomaterials·2025· 8 cited
Itacitinib for prevention of graft-versus-host disease and cytokine release syndrome in haploidentical transplantation
Blood·2024· 5 citedOpen Access
Novel JAK Inhibitors to Reduce Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation in a Preclinical Mouse Model
Molecules·2024· 4 citedOpen Access
Abstract 248: HSPA9/mortalin regulates erythroid maturation through a TP53-dependent mechanism in human CD34+ hematopoietic progenitor cells
Cancer Research·2024
HSPA9/mortalin inhibition disrupts erythroid maturation through a TP53-dependent mechanism in human CD34+ hematopoietic progenitor cells
Cell Stress and Chaperones·2024· 6 citedOpen Access
Baricitinib with cyclosporine eliminates acute graft rejection in fully mismatched skin and heart transplant models
Frontiers in Immunology·2023· 5 citedOpen Access
S100A8 and S100A9 in Hematologic Malignancies: From Development to Therapy
International Journal of Molecular Sciences·2023· 16 citedOpen Access
Phase I-II Trial of Early Azacitidine after Matched Unrelated Donor Hematopoietic Cell Transplantation
Transplantation and Cellular Therapy·2023· 2 citedOpen Access
PKN1 is a novel therapeutic target to prevent graft-vs-host disease after allogeneic hematopoietic cell transplantation
The Journal of Immunology·2023· 2 citedOpen Access
Overexpression of S100A9 in donor T cells is associated with reconstitution of gut microbiota and outcome of allogeneic hematopoietic stem cell transplantation
Blood Research·2023· 2 citedOpen Access
The adrenal stress response is an essential host response against therapy-induced lethal immune activation
Science Signaling·2023· 3 citedOpen Access
A Multicenter Phase 2 Clinical Trial of 10-Day Decitabine, Dose-Escalated Donor Lymphocyte Infusion, and Ruxolitinib for Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Cell Transplantation
Transplantation and Cellular Therapy·2023· 4 citedOpen Access
Abstract 2125: PKN1 is a novel therapeutic target to prevent graft-vs-host disease after allogeneic hematopoietic cell transplantation
Journal of Biological Chemistry·2023Open Access
Restoring NK cell functions in AML relapse
Blood·2022· 6 citedOpen Access
S100A9 upregulated by IFNGR signaling blockade functions as a novel GVHD suppressor without compromising GVL in mice
Blood·2022· 4 citedOpen Access
Phase I Study of Baricitinib Gvhd Prophylaxis in HLA-Matched, Peripheral Blood Allogeneic Hematopoietic Cell Transplant
Blood·2022· 4 cited
Combined Treatment of Baricitinib and Cyclosporin Prevents Solid Organ Graft Rejection in Mice
Transplantation and Cellular Therapy·2022
Editorial: Interferons and GvHD
Frontiers in Immunology·2022Open Access
Mouse models of graft-versus-host disease
Methods in cell biology·2022· 9 cited
page 1 of 4Next →

Frequent Co-authors

John F. DiPersio(39), Julie Ritchey(22), Matthew Cooper(20), Mark A. Schroeder(15), Sena Kim(11), Karl Staser(9), Sora Lim(8), Iskra Pusic(7), Geoffrey L. Uy(7), Peter Westervelt(7), Armin Ghobadi(6), Feng Gao(6), Ravi Vij(6), Keith Stockerl‐Goldstein(6), Kiran Vij(6), Julie L. Prior(5), Matthew Holt(5), Camille N. Abboud(5), Bader Alahmari(5), Michael P. Rettig(4)